"A novel mode of action which has generated a degree of excitement" - Paul Emery PD-1 agonist - peresolimab in RA Good impact in b/tsDMARD refractory patients "Correction of an immune state" - we're shooting for homestasis Definitely a space to watch! ABSTL01 #ACR22 @RheumNow https://t.co/W2lWrBgNOT